CARGO Therapeutics, Inc. (CRGX)

NASDAQ: CRGX · IEX Real-Time Price · USD
16.18
+0.54 (3.45%)
Dec 5, 2023, 10:50 AM EST - Market open
3.45%
Market Cap 625.72M
Revenue (ttm) n/a
Net Income (ttm) -56.63M
Shares Out 38.67M
EPS (ttm) -1.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,179
Open 16.62
Previous Close 15.64
Day's Range 15.90 - 17.24
52-Week Range 13.14 - 17.29
Beta n/a
Analysts Strong Buy
Price Target 28.33 (+75.09%)
Earnings Date n/a

About CRGX

CARGO Therapeutics is a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients. Our programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Our lead program, CRG-022, which we exclusively licensed from the National Cancer Institute, is being studied by Stanford University in a Phase 1 clinical trial in patients with large B-cell lymphoma (LBCL) wh... [Read more]

Industry Biotechnology
Sector Healthcare
IPO Date Nov 10, 2023
Employees 74
Stock Exchange NASDAQ
Ticker Symbol CRGX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for CRGX stock is "Strong Buy." The 12-month stock price forecast is $28.33, which is an increase of 75.09% from the latest price.

Price Target
$28.33
(75.09% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Cargo Therapeutics IPO prices at $15 a share, low end of proposed range

Cargo Therapeutics CRGX, , a clinical-stage biotech specializing in cancer treatments, said late Thursday its initial public offering priced at $15 a share, the low end of its range. The company sold ...

25 days ago - Market Watch

CARGO Therapeutics Announces Pricing of Initial Public Offering

CARGO Therapeutics, Inc., a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies...

25 days ago - GLOBE NEWSWIRE

Cargo Therapeutics to offer 18.8 million shares in IPO priced at $15 to $17 each

Cargo Therapeutics CRGX, , a clinical-stage biotech specializing in cancer treatments, set terms for its initial public offering early Monday with plans to offer 18.8 million shares priced at $15 to $...

4 weeks ago - Market Watch

CARGO Therapeutics IPO Registration Document (S-1)

CARGO Therapeutics has filed to go public with an IPO on the NASDAQ.

6 weeks ago - SEC